PMID 15688030
To mitigate weight regain: Establish sustainable dietary changes before stopping Maintain regular physical activity Consider working with a dietitian Discuss alternative weight management strategies with your GP For diabetes management , your healthcare team will need to adjust your treatment plan
In REDEFINE 1 , a 68-week, Phase 3a, multicenter, double-blind, placebo- and active-controlled trial, 3,417 adults with overweight or obesity but without diabetes were randomized to CagriSema (cagrilintide 2.4 mg + semaglutide 2.4 mg), semaglutide 2.4 mg, cagrilintide 2.4 mg, or placebo
Oklahoma, Louisiana, Mississippi, Missouri, and Ohio all report smoking rates of 15% or higher
Effect of nesiritide in patients with acute decompensated heart failure